Cleveland Biolabs Inc. Announces Changes to Board of Directors

Published: Apr 23, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BUFFALO, N.Y., April 23, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced that its board of directors has appointed Julia Brown and Anthony Principi as new independent directors and David Hohn, M.D., a current director, as Chairman of the board. Bernard Kasten, M.D. and Michael Fonstein, Ph.D., will retire from the board at the Company's 2013 annual meeting of shareholders, following the expiration of their current terms.

Help employers find you! Check out all the jobs and post your resume.

Back to news